![Julien Mamet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Julien Mamet is a Director & Chief Scientific Officer at Adynxx, Inc. He is on the Board of Directors at Adynxx, Inc. Dr. Mamet was previously employed as a Director & Chief Scientific Officer by Adynxx, Inc. (Old).
He received his undergraduate degree from Université Claude Bernard Lyon 1 and a graduate degree from Université Claude Bernard Lyon 1.
| Companies | Position | End |
|---|---|---|
| ADYNXX, INC. | Chief Executive Officer | 2010-11-30 |
Adynxx, Inc. (Old)
 Adynxx, Inc. (Old) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Founder | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Adynxx, Inc. (Old)
Adynxx, Inc. (Old) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Université Claude Bernard Lyon 1
 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adynxx, Inc.
 Adynxx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops and markets novel & disease-modifying products for treatment of pain and inflammation | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
